RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK)
13.20
0.00 (0.00%)
At close: Jan 23, 2026
ETR:RHK Revenue
RHÖN-KLINIKUM Aktiengesellschaft had revenue of 498.00M EUR in the quarter ending September 30, 2025, with 7.60% growth. This brings the company's revenue in the last twelve months to 1.95B, up 6.41% year-over-year. In the year 2024, RHÖN-KLINIKUM Aktiengesellschaft had annual revenue of 1.87B with 7.67% growth.
Revenue (ttm)
1.95B
Revenue Growth
+6.41%
P/S Ratio
0.45
Revenue / Employee
102.57K
Employees
14,067
Market Cap
883.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.87B | 133.13M | 7.67% |
| Dec 31, 2023 | 1.73B | 73.57M | 4.43% |
| Dec 31, 2022 | 1.66B | 69.95M | 4.40% |
| Dec 31, 2021 | 1.59B | 45.15M | 2.92% |
| Dec 31, 2020 | 1.55B | 65.12M | 4.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.87B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.27B |
| Redcare Pharmacy NV | 2.82B |
| Gerresheimer AG | 2.25B |
| Medios AG | 2.01B |
| Dermapharm Holding SE | 1.17B |
RHÖN-KLINIKUM Aktiengesellschaft News
- 11 days ago - RHÖN-KLINIKUM Adjusts 2025 EBITDA Forecast: What Investors Need to Know - Wallstreet:Online
- 11 days ago - EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft adjusts the EBITDA forecast for financial year 2025 - Wallstreet:Online
- 2 months ago - Rhoen-Klinikum's Q3 2025: Solid Results Drive Growth - Wallstreet:Online
- 6 months ago - Rhoen-Klinikum Shines in H1 2025 with Strong Performance - Wallstreet:Online
- 9 months ago - Rhoen-Klinikum Steady in Q1 2025, Confirms Positive Outlook - Wallstreet:Online
- 10 months ago - Rhoen-Klinikum's Prof. Kaltenbach Exits After Stellar Year - Wallstreet:Online
- 10 months ago - EQS-News: RHÖN-KLINIKUM AG once again reports a successful financial year – CEO Prof. Kaltenbach leaves the Board of Management as planned - Wallstreet:Online
- 1 year ago - Rhoen-Klinikum Shines: Strong 9-Month Performance, Outlook Confirmed - Wallstreet:Online